Biotech entity

Centers for Medicare and Medicaid Services

Company

All 1 tracked stories fall under one category: pharma. Eli Lilly is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Centers for Medicare and Medicaid Services appears in 1 tracked Biotech story from July 21, 2026.

Last mentioned: Aug 13, 2026

Entity pulse

Recent coverage · Centers for Medicare and Medicaid Services

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Centers for Medicare and Medicaid Services

All 1 tracked stories fall under one category: pharma. Eli Lilly is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Centers for Medicare and Medicaid Services appears in 1 tracked Biotech story from July 21, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Centers for Medicare and Medicaid Services. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Medicare GLP-1 Bridge pilot launches

    CMS begins covering Wegovy and Zepbound for weight loss under a temporary pilot, offering potential $50 copays for eligible beneficiaries instead of $1,000+ list prices.

Stories mentioning Centers for Medicare and Medicaid Services 1

Centers for Medicare and Medicaid Services is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.